Patent application number | Description | Published |
20080312307 | MAPK/ERK KINASE INHIBITORS - Compounds are provided for inhibition of MEK that comprise: | 12-18-2008 |
20090012059 | DIPEPTIDYL PEPTIDASE INHIBITORS - Compounds, pharmaceuticals, kits and methods are provided for use with DPP-IV and other S9 proteases that comprise a compound comprising: | 01-08-2009 |
20090156557 | KINASE INHIBITORS - Compounds are provided for use with kinases that comprise a compound selected from the group consisting of: | 06-18-2009 |
20090275750 | DIPEPTIDYL PEPTIDASE INHIBITORS - Methods of making compounds of the formula (I) wherein the variables are as defined herein. Also, methods of making compounds that may be used to inhibit dipeptidyl peptidase. | 11-05-2009 |
20090281092 | POLO-LIKE KINASE INHIBITORS - Compounds of the following formula are provided for use with kinases: | 11-12-2009 |
20090286800 | Glucokinase Activators - Compounds are provided for use with glucokinase that comprise the formula: | 11-19-2009 |
20090291938 | POLO-LIKE KINASE INHIBITORS - Compounds of the following formula are provided for use with kinases: | 11-26-2009 |
20090305998 | HSP90 INHIBITORS - The invention relates to HSP90 inhibiting compounds consisting of the formula: | 12-10-2009 |
20090312288 | KINASE INHIBITORS - Compounds are provided for use with kinases that comprise a compound selected from the group consisting of: | 12-17-2009 |
20100063054 | cMET INHIBITORS - Compounds of the following formula are provided for use with cMET: | 03-11-2010 |
20100069431 | IMIDAZOPYRIDINE COMPOUNDS - Compounds, pharmaceutical compositions, kits and methods are provided for use with glucokinase that comprise a compound selected from the group consisting of formula (I) wherein the variables are as defined herein. | 03-18-2010 |
20100075973 | POLO-LIKE KINASE INHIBITORS - The present invention provides PLK inhibitors of the formula | 03-25-2010 |
20100093767 | Mitotic Kinase Inhibitors - The invention relates to inhibitors of enzymes that disrupt the assembly and function of the mitotic spindle, compositions comprising the inhibitors of Formula (I), kits and articles of manufacture comprising the inhibitors and inhibitor compositions, and methods of using the inhibitors and inhibitor compositions. The inhibitors and inhibitor compositions are useful for treating, preventing or modulating diseases in which mitotic kinesins, including kinesin-like spindle protein (KSP), may be involved; symptoms of such diseases; or the effect of other physiological events mediated by mitotic kinesins, including KSP. | 04-15-2010 |
20100120717 | KINASE INHIBITORS - Compounds are provided for use with kinases that comprise a compound selected from the group consisting of formula (I) wherein the variables are as defined herein. Also provided are pharmaceutical compositions, kits and articles of manufacture in comprising such compounds; methods and intermediates useful for making the compounds; and methods of using said compounds. | 05-13-2010 |
20100160633 | KINASE INHIBITORS - Compounds are provided for use with kinases that comprise a compound selected from the group consisting of: | 06-24-2010 |
20100190816 | KINASE INHIBITORS - Compounds, pharmaceutical compositions, kits and methods are provided for use with kinases that comprise a compound selected from the group consisting of: | 07-29-2010 |
20100216765 | KINASE INHIBITORS - Compounds, pharmaceutical compositions and kits are provided for use with kinases that comprise a compound selected from the group consisting of: | 08-26-2010 |
20110053873 | HSP90 INHIBITORS - The invention relates to HSP90 inhibiting compounds consisting of the formula: (I) wherein the variables are as defined herein. The invention also relates to pharmaceutical compositions, kits and articles of manufacture comprising such compounds; methods and intermediates useful for making the compounds; and methods of using said compounds. | 03-03-2011 |
20110082111 | POLO-LIKE KINASE INHIBITORS - Compounds of the following formula are provided for use with kinases: | 04-07-2011 |
20110087022 | Dipeptidyl Peptidase Inhibitors - Compounds, pharmaceuticals, kits and methods are provided for use with DPP-IV and other S9 proteases that comprise a member selected from the group consisting of: | 04-14-2011 |
20110201818 | POLO-LIKE KINASE INHIBITORS - Compounds of the following formula are provided for use with kinases: | 08-18-2011 |
20110275665 | GLUCOKINASE ACTIVATORS - Compounds are provided for use with hexokinases that comprise: | 11-10-2011 |
20120095233 | KINASE INHIBITORS - Compounds are provided for use with kinases that comprise a compound selected from the group consisting of: | 04-19-2012 |
20120172321 | HSP90 INHIBITORS - The invention relates to HSP90 inhibiting compounds consisting of the formula: | 07-05-2012 |
20120225887 | Glucokinase Activators - Compounds are provided for use with glucokinase that comprise the formula: | 09-06-2012 |
20120252761 | KINASE INHIBITORS - Compounds are provided for use with kinases that comprise a compound selected from the group consisting of: | 10-04-2012 |
20120264770 | HSP90 INHIBITORS - The invention relates to HSP90 inhibiting compounds consisting of the formula: | 10-18-2012 |
20140045859 | Glucokinase Activators - Compounds are provided for use with glucokinase that comprise the formula: | 02-13-2014 |